Q/C TECHNOLOGIES, INC. — Director's Dealing 2016

Jan 5, 2016

SEC Form 4/A — Form 4/A

Issuer: Akers Biosciences Inc (AKER)
CIK: 0001321834
Period of Report: 2015-01-09

Reporting Person: Knox Thomas J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-09	Common Stock	A	50000	—	Acquired	408150	Direct

Footnotes

F1: Such shares were issued under Akers Biosciences, Inc.'s Amended and Restated 2013 Incentive Stock and Award Plan.

F2: The Form 4 filed on January 12, 2015 for Mr. Knox incorrectly listed the amount of common stock beneficially owned as 466,666. At such time, Mr. Knox beneficially owned 408,150 shares of common stock. This amended Form 4 represents the correct total amount of common stock beneficially owned by Mr. Knox as of January 12, 2015.